Chapter 401: Shocking Scam
"Through hundreds of accounts at several overseas financial companies, the total short-selling amount is more than 12 million, with a leverage of 20 times, and the expected profit is around 125 million US dollars." Andy introduced with a smile.
Good guys,
If all goes well, this operation could earn more than $100 million.
But it will definitely kill many people.
Capitalists are so greedy that they drink blood and eat flesh. The road to their growth is littered with piles of bones.
"What are you going to do next?" Hardy asked Andy.
"In fact, we don't need to do anything now. We just need to wait for the market to react. With such big news, people will keep digging deeper and it will eventually explode completely," said Andy.
Hardy nodded.
He thought of a sentence:
Sit and watch the clouds roll by, listen quietly to the flowers bloom and fall, and let the tides rise and fall.
During this time,
He is going to see a play in America.
Back to the manor,
I called the French girl Irena to come over. I haven't seen Irena for a long time. This time I flipped over her card first. I have to say, this girl has the best legs among all the women in Hardy's collection.
......
The Los Angeles Financial Times suddenly broke the news about "Hans Pharmaceuticals", which immediately detonated the stock market. Hans Pharmaceuticals first experienced a panic decline, but it stabilized after a short time. After all, this was just a rumor and had not been confirmed.
But it has also caused distrust in the market.
However, no one is willing to take over Hans Pharmaceuticals shares now. As for the stable stock price, it is because those who hold the stocks do not want to sell them, and no one is buying them in the market, so the price remains stable.
This matter,
U.S. stock market attention.
Japan is also paying close attention.
All news outlets reported on this incident, causing panic among many Japanese, because those who invest know that financial companies in Japan have invested large sums of money in Hans Pharmaceutical.
If Hans Pharmaceuticals plummets, their investment will be gone.
So many people became very nervous during this period.
Two days later.
Hardy got up and prepared to exercise. Elizabeth Taylor was still sleeping soundly on the bed. Hardy had given her a good beating last night, and she was so tired that she couldn't wake up in the morning.
After working out in the gym and taking a shower, Hardy went to the restaurant to have breakfast while reading the newspaper while Taylor was still asleep.
Today, the New York Times also published a report about "Hans Pharmaceuticals", and the content was even more explosive than the previous two days.
"It was confirmed that Hans was counterfeiting drugs, and African officials confirmed that his human drug experiments in Africa were far from ideal."
"The New York Times correspondent stationed in Africa found the place where Hans Pharmaceuticals conducted human experiments. Local officials told us that they conducted a surprise inspection of Hans Pharmaceuticals' experiments and found that the drug used by Hans Pharmaceuticals was not simply the reported drug 'ethambutol', but 'ethambutol' and 'streptomycin' were used together. Because they didn't know which drug had an effect on the patients, they have now determined that all of Hans Pharmaceuticals' experimental data is unqualified and they need to re-experiment."
"Hans Pharmaceuticals previously advertised that their research product, 'Ethambutol', was a special medicine. Why did they use it together with streptomycin? This is obviously a fraud. We seriously suspect that Hans Pharmaceuticals did this to increase the stock price and defraud investors of their money."
"We also interviewed researchers who used to work at Hans Pharmaceuticals. According to several researchers, before Dr. Hans announced that he had developed a specific drug for tuberculosis, many of Hans Pharmaceuticals' research projects had come to a standstill. Hans Pharmaceuticals' stock price had already fallen to the bottom, and it had borrowed a large amount of money from banks. It was already in trouble, all projects were completely stopped, and it even owed many people wages. At this time, Dr. Hans suddenly announced that he had found a specific drug for tuberculosis, and the stock price rose wildly. Judging from this series of operations, there is a very strong suspicion of fraud."
As this report came out.
After holding up for two days, the stock price of Hans Pharmaceuticals collapsed. The US stocks did not stop trading, so the decline of Hans Pharmaceuticals was like a madman, and it plummeted rapidly.
In fact, Hans Pharmaceuticals has always been a concept stock. People buy its expectations of success. Once the research is successful, there will be a broad market and money prospects, and people are willing to buy its stocks.
Of course,
The main reason why Hans Pharmaceuticals has such a high stock price is due to hype, because even if it is a good concept stock, it is impossible to reach such a high price.
This has to say a lot about Andy's strength and previous layout, which turned an expected stock into a great stock.
When the market closes,
Hans Pharmaceuticals has fallen from over $80 per share to $20 per share, a reduction of four-fifths from its peak.
Hardy knew this wasn't the end.
The next day.
The Los Angeles Times once again reported that Hans Pharmaceuticals has attracted the attention of the China Securities Regulatory Commission, which has decided to investigate its situation. If fraud is indeed involved, Hans Pharmaceuticals may face a suspension of trading and the relevant responsible persons may be held legally accountable.
The shareholders who held Hans Pharmaceuticals in their hands were all shocked.
There is no point in holding those responsible accountable.
They want money.
Once the stock is suspended, all the stocks they hold will become worthless. Many people rush to the stock market and start frantically selling their stocks.
But at this time, who is willing to be a fool and take over?
As panic spread, the stock price of Hans Pharmaceuticals fell sharply again, and by the close of trading it was only $3 per share.
After working hard for a whole year, we are back to the time before liberation in just three days.
This is not the bottom yet.
Because the stock pit will never have a bottom, it will only go lower and lower, with no bottom in sight.
......
A few days later,
Monroe is back.
These days she is filming "The Seven Year Itch" in New York, which is another classic of hers and the source of the classic shot of the white dress flying.
night,
Monroe tried on all the costumes in the play for Hardy, including the white halter dress.
Then Monroe wore the white dress and accepted Hardy's favor.
Enjoy life to the fullest when you are happy.
......
That evening.
A financial program on ABC TV reported a breaking news that the U.S. Securities and Exchange Commission investigated Hans Pharmaceuticals and found that there were indeed major problems.
This financial program started out as Andy's stock recommendation program, and later gradually evolved into a stock analysis and investment analysis program.
After Andy became the president of Hardy Company, he rarely participated in this program and has trained several economic experts.
The host reported the situation:
According to the investigation results, Dr. Hans did give some people drugs containing streptomycin when conducting experiments.
As for the new drug he was researching, its effectiveness was still uncertain because Hans was conducting a cross-mixing experiment and all the experimental data was in his control.
Not too many conclusions can be drawn from these data, but the problem now is that Dr. Hans disappeared. They found Africa and discovered that human experiments there had been stopped for about two weeks, and Dr. Hans was no longer in charge and his whereabouts are now unknown.
The SEC also found out that long before Dr. Hans announced the discovery of a specific drug for tuberculosis, he had already sold all of his pharmaceutical company's shares to a company registered in South Africa for a total of US$800,000.
Therefore, Hans Pharmaceuticals no longer belonged to Dr. Hans in the later period.
When the stock price of that South African company soared, it sold all its shares to other companies. The current major shareholders of the company are several financial investment companies that took over at a high price.
Now, the funds of the South African company have already been transferred, and the company is now just an empty shell. As for the flow of funds, there is no way to trace it because the company is not involved in any illegal activities.
The host looked at the economic expert and asked, "Professor Rice, you are an expert in finance. Do you think Hans Pharmaceuticals is still worth investing in?"
Professor Rice shook his head: "From the current situation, this transaction looks very much like a scam. Of course, we can't be completely sure, but the current risk level can be said to have been raised to the highest level. We invest to make money, not to trigger landmines, so I advise everyone to stay away from this stock."
"For those who hold shares, good luck to them."
The next morning's newspaper reported the results of the CSRC's investigation. Since Dr. Hans was missing and the research data had not been obtained, the drug counterfeiting could not be confirmed. It was necessary to wait for confirmation before deciding whether to suspend trading, so it was announced that there would be no suspension in the near future.
But this may not be good news for the majority of investors, because Dr. Hans may have already run away.
When you buy this stock, you are buying into the expectations of the drug's success.
Now the expectation is gone.
This company is just an empty shell and has no investment value at all.
As the report came out,
The stock price of Hans Pharmaceuticals collapsed again, dropping to just a few cents in just one day.
Many investors cried.
Because this stock made them lose all their money.
In fact, the shareholders are relatively lucky. The financial companies that bought shares of this company are the ones who suffered the real loss. The shares they bought at the beginning cost tens of millions of dollars, but now they are worthless.
Andy thought that was enough.
One cannot be too greedy. He asked someone to end the short selling. In less than a month, the entire operation helped Hardy earn more than 100 million US dollars.
This time, it is not only the shareholders who are wailing, but also many American domestic financial institutions. They took the short-selling orders and naturally have to bear the risks.
Hardy still has no psychological burden about making money from these American financial institutions.